ALEMBIC Financial Statement Analysis
|
||
|
The Revenues of ALEMBIC have increased by 23.77% YoY .
The Earnings Per Share (EPS) of ALEMBIC has increased by 40.97 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
ALEMBIC Last 5 Annual Financial Results
[BOM: 506235|NSE : ALEMBICLTD]
| Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹157 Cr | ₹127 Cr | ₹78 Cr | ₹74 Cr | ₹74 Cr |
| Expenses | ₹101 Cr | ₹87 Cr | ₹64 Cr | ₹63 Cr | ₹71 Cr |
| Operating Profit (Excl OI) | ₹57 Cr | ₹40 Cr | ₹14 Cr | ₹10 Cr | ₹3.14 Cr |
| Other Income | ₹55 Cr | ₹64 Cr | ₹89 Cr | ₹11 Cr | ₹94 Cr |
| Interest | ₹1.11 Cr | ₹0.47 Cr | ₹0.39 Cr | ₹0.36 Cr | ₹0.29 Cr |
| Depreciation | ₹7.84 Cr | ₹6.72 Cr | ₹4.86 Cr | ₹3.94 Cr | ₹3.23 Cr |
| Profit Before Tax | ₹103 Cr | ₹87 Cr | ₹98 Cr | ₹17 Cr | ₹93 Cr |
| Profit After Tax | ₹93 Cr | ₹81 Cr | ₹86 Cr | ₹14 Cr | ₹93 Cr |
| Consolidated Net Profit | ₹269 Cr | ₹191 Cr | ₹222 Cr | ₹343 Cr | ₹329 Cr |
| Earnings Per Share (Rs) | ₹10.46 | ₹7.42 | ₹8.65 | ₹13.35 | ₹12.82 |
| PAT Margin (%) | 58.97 | 63.36 | 110.20 | 18.83 | 125.85 |
| ROE(%) | 4.36 | 3.52 | 3.60 | 0.75 | 7.08 |
| ROCE(%) | 4.86 | 3.82 | 4.10 | 0.94 | 7.12 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 3,582.4 Cr |
| Revenue (TTM) | : | ₹ 192.1 Cr |
| Net Profit(TTM) | : | ₹ 125.9 Cr |
| EPS (TTM) | : | ₹ 4.9 |
| P/E (TTM) | : | 28.4 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| ALEMBIC | -5.5% | 13% | 56.2% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.1% | 1.7% | 45.7% |
| CIPLA | 1.7% | 0.5% | 23.7% |
| DR REDDYS LABORATORIES | 5.7% | 12.4% | 18.5% |
| ZYDUS LIFESCIENCES | -1.4% | 3.1% | 44.8% |
| DIVIS LABORATORIES | -0.1% | -2.2% | 56.9% |
| MANKIND PHARMA | 4.2% | 9.8% | 49.8% |
| TORRENT PHARMACEUTICALS | 2.2% | 10.6% | 61.7% |
| LUPIN | 4.1% | 5.1% | 71.7% |
ALEMBIC Revenues
[BOM: 506235|NSE : ALEMBICLTD]
| Y-o-Y | 23.77 % |
| 5 Yr CAGR | 20.81 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹157 Cr | 23.77 | |
| Mar2023 | ₹127 Cr | 62.68 | |
| Mar2022 | ₹78 Cr | 6.40 | |
| Mar2021 | ₹74 Cr | -0.55 | |
| Mar2020 | ₹74 Cr | - | |
ALEMBIC Operating Profit
[BOM: 506235|NSE : ALEMBICLTD]
| Y-o-Y | 40.98 % |
| 5 Yr CAGR | 106.29 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹57 Cr | 40.98 | |
| Mar2023 | ₹40 Cr | 189.55 | |
| Mar2022 | ₹14 Cr | 33.59 | |
| Mar2021 | ₹10 Cr | 232.07 | |
| Mar2020 | ₹3.14 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 13.91 % |
| 5 Yr CAGR | 70.73 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 36.11% | 13.91 | |
| Mar2023 | 31.7% | 77.99 | |
| Mar2022 | 17.81% | 25.60 | |
| Mar2021 | 14.18% | 233.65 | |
| Mar2020 | 4.25% | - | |
ALEMBIC Profit After Tax
[BOM: 506235|NSE : ALEMBICLTD]
| Y-o-Y | 40.90 % |
| 5 Yr CAGR | -4.95 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹269 Cr | 40.90 | |
| Mar2023 | ₹191 Cr | -14.14 | |
| Mar2022 | ₹222 Cr | -35.23 | |
| Mar2021 | ₹343 Cr | 4.17 | |
| Mar2020 | ₹329 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -6.93 % |
| 5 Yr CAGR | -17.26 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 58.97 % | -6.93 | |
| Mar2023 | 63.36 % | -42.50 | |
| Mar2022 | 110.2 % | 485.24 | |
| Mar2021 | 18.83 % | -85.04 | |
| Mar2020 | 125.85 % | - | |
ALEMBIC Earnings Per Share (EPS)
[BOM: 506235|NSE : ALEMBICLTD]
| Y-o-Y | 40.97 % |
| 5 Yr CAGR | -4.96 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹10 | 40.97 | |
| Mar2023 | ₹7.42 | -14.22 | |
| Mar2022 | ₹8.65 | -35.21 | |
| Mar2021 | ₹13 | 4.13 | |
| Mar2020 | ₹13 | - | |
ALEMBIC Return on Capital Employed (ROCE)
[BOM: 506235|NSE : ALEMBICLTD]
| Y-o-Y | 27.23 % |
| 5 Yr CAGR | -9.11 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 4.86% | 27.23 | |
| Mar2023 | 3.82% | -6.83 | |
| Mar2022 | 4.1% | 336.17 | |
| Mar2021 | 0.94% | -86.80 | |
| Mar2020 | 7.12% | - | |
ALEMBIC Share Price vs Sensex
| Current Share Price | : | ₹139.5 |
| Current MarketCap | : | ₹ 3,582.4 Cr |
| Updated EOD on | : | Dec 20,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC | -5.5% |
13% |
56.2% |
| SENSEX | -5% |
0.6% |
9.2% |
ALEMBIC related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE ALLCAP | -0.3% | -3.5% | 35.8% |
| S&P BSE SMALL CAP | -3.2% | 5.1% | 31.1% |
| S&P BSE MIDSMALLCAP | -3.2% | 4.4% | 29.5% |
| S&P BSE CONSUMER DISC. | -3.6% | 1.7% | 25.8% |
No NSE index found
You may also like the below Video Courses
FAQ about ALEMBIC Financials
How the annual revenues of ALEMBIC have changed ?
The Revenues of ALEMBIC have increased by 23.77% YoY .
How the Earnings per Share (EPS) of ALEMBIC have changed?
The Earnings Per Share (EPS) of ALEMBIC has increased by 40.97 % YoY .
Check out Intrinsic Value of Peers of ALEMBIC
Compare Stock Analytics of Peers of ALEMBIC
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
